OxyContin maker Purdue Pharma reaches $8.34 bil settlement, pleads guilty for role in opioid case
The settlement with the DOJ ends years of litigation against the now bankrupt maker of OxyContin
The Department of Justice reached an $8.34 billion settlement with Purdue Pharma, the maker of OxyContin, said the department on Wednesday.
The company, now bankrupt, will be required to turn over future profits to cities and states that accuse it of playing a meaningful role in facilitating the opioid crisis. Purdue has also agreed to plead guilty to three counts pertaining to payments to healthcare providers.
Wednesday’s announcement puts an end to the years-long case that investigated the marketing and distribution of the powerful painkiller.
Despite the fact that the current assets of Purdue Pharma fall well short of $8 billion, the Sackler family, who own the company, will contribute $225 million to resolve separate civil claims and the company will pay $225 million to the federal government.
Today’s deal does not prevent the government from filing suits against the owners of Purdue in the future.
News, Not Noise
- Whistleblowers allege ballots illegally crossed state lines, ballot backdating, digital manipulation
- Project Veritas claims it has been secretly recording CNN's Jeff Zucker executive calls
- CEO of oilfield service business predicts Biden administration will be a boon to oil investors
- Trump demands social media giants' liability shield be scrapped, threatens defense bill veto
- Judge allows Trump campaign attorneys to review tests of Clark County voting equipment